Ivabradine treatment for chronic heart failure in clinical practice is associated with reductions in symptoms and hospitalizations with improved quality of life, independent of beta blocker dose
Kardiologische Praxis im Steiner Thor, Straubing (Germany)
0
follower
9
more
presentations
in this session
Assessment of the use of ESC heart failure guideline recommended therapy among patients followed at a heart failure outpatient clinic participating in the ESC Heart Failure long-term Registry
Long-term follow up of hospitalized patients with systolic heart failure undergoing early treatment with beta-blockers more ivabradine: a randomized study